Personalizing
Cancer Treatment for Everyone
IN THE NEWS
Dr. Belisario and Kim Thiboldeaux

Massive Bio Team Meets with the Cancer Moonshot Project and the Biden Cancer Initiative in Washington, D.C.

On June 27, 2017,  a member of the Massive Bio Team, Belisario A. Arango, M.D., took part of the Cancer Moonshot Project and the Biden Cancer Initiative Meeting in Washington, D.C.  The meeting was hosted by Kim Thiboldeaux, CEO of Cancer Support Community and a member of the Board of Directors of the Biden Cancer  Initiative. The purpose of this meeting was to update the cancer community on the accomplishments over the past year, since the announcement of the Moonshot challenge, and to discuss the goals that are expected to be reached over the next 4 years.

The market for oncology medication is booming, aiding the overall pharmaceutical industry growth

The market for oncology medication is booming, aiding the overall pharmaceutical industry growth. The oncology drug market is estimated to be almost USD 94 billion. Most of the top pharmaceutical players are either currently manufacturing oncology drugs or have oncology medications in their R&D pipelines.

DNA-based analysis identifies risk factor for metastasis of uveal melanoma

DNA-based analysis of cytogenetic abnormalities identified correlations of clinical features in patients with uveal melanoma—namely, that larger ocular melanomas and older patient age are associated with increased risk for metastasis. Small-to-medium uveal melanomas are associated with lower metastatic risk.

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research.

 

Genetic analysis enables personalized cancer treatment

Cancer genomics, the use of individual genetic information to figure out the most effective treatment, is set to bring about great changes in cancer treatment. 

Periodontal Disease is Associated with Higher Risk of Several Cancer Types

Periodontal disease was associated with increased risk of several types of cancer in postmenopausal women, even in women who had never smoked, according to results of a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Nivolumab Approved for Patients with Chemotherapy-Resistant, Metastatic, MSI-H Colorectal Cancer

A subset of patients with metastatic colorectal cancer (mCRC) for which standard chemotherapy is ineffective can now receive the immunotherapy nivolumab (Opdivo®, Bristol-Myers Squibb).

What Is a Tumor Board? An Expert Q&A

Your doctor says to you, "We discussed your case at our tumor board, and here is your treatment recommendation." So, what exactly is a tumor board and what role does it play in your cancer care?share on twitter This Q&A explains.

New agent blocks growth of recurring breast cancer tumors

Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors.

New cervical cancer vaccine may almost eliminate disease, research shows

Cervical cancer could be almost completely eliminated, research has found, thanks to a new vaccine being reviewed by Australia's pharmaceutical authority.

Do you know that August is Summer Sun Safety month?

Summer Sun Safety Month, observed in August, encourages you to enjoy your summer, but take precautions to avoid overexposure to the sun’s ultraviolet rays. And if you notice anything unusual on your skin, see your provider.

 

Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us by one of the options listed below:
Give Us a Call
+1 (917) 336-3319
PLEASE FILL OUT FORM BELOW

X
Talk to Cancer Care Experts:
1 (844) 627-7246
Top